Get Instant Summarized Text (Gist) A novel class of zwitterionic phospholipids, specifically DOPE-Cx, significantly enhances mRNA delivery by facilitating endosomal escape, a major challenge in ...

It’s no surprise, then, that SYK stock carries a moderate buy consensus ... a vaccine during the Covid-19 crisis, Moderna (NASDAQ:MRNA) discovers, develops and commercializes messenger-RNA ...

In a report released on April 15, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Stryker (SYK – Research Report), with a price target of $435.00. Discover outperforming stocks ...